MTI 100: Global Medtech Recovers Core Growth After A Year Like No Other
Commentary on dynamics and influential factors for companies in MTI's Top 100 Medtech Listings for 2022-23
With many medtechs restructuring for core growth in the post-pandemic era, Abbott relied on organic growth in 2022 to move to the top of the global medtech ranking. The strength of the US dollar was not kind to companies reporting in local currencies on converting revenues to dollars.
